Cabaletta Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cabaletta Bio and other ETFs, options, and stocks.About CABA
Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies.
CEOSteven Nichtberger
CEOSteven Nichtberger
Employees161
Employees161
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2017
Founded2017
Employees161
Employees161
CABA Key Statistics
Market cap146.61M
Market cap146.61M
Price-Earnings ratio-0.64
Price-Earnings ratio-0.64
Dividend yield—
Dividend yield—
Average volume2.27M
Average volume2.27M
High today$1.68
High today$1.68
Low today$1.56
Low today$1.56
Open price$1.60
Open price$1.60
Volume930.39K
Volume930.39K
52 Week high$8.77
52 Week high$8.77
52 Week low$0.9857
52 Week low$0.9857
Analyst ratings
82%
of 11 ratingsBuy
81.8%
Hold
18.2%
Sell
0%
People also own
Based on the portfolios of people who own CABA. This list is generated using Robinhood data, and it’s not a recommendation.